On Wednesday, Shares of Intel Corporation (NASDAQ:INTC), gained 1% to $31.95.
Intel Corporation, is laying off a few hundred people this week at its Chandler campus after disappointing personal computer sales didn’t meet expectations in the first quarter, according to American City Business Journals.
The Portland Business Journal is reporting that Intel CEO Brian Krzanich confirmed the layoffs at the company’s Oregon facility in addition to other company locations after an internal memo was leaked to the media.
A local Intel (Nasdaq: INTC) spokeswoman said, the company is not commenting on the reports because they are based on internal documents. Semiconductor-maker Intel is based in Santa Clara, California.
Intel topped the Phoenix Business Journal’s Manufacturers list since the list was revised in 2011.
Intel employs about 11,000 in Chandler. American City Business Journals added.
Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.
Shares of U.S. Bancorp (NYSE:USB), inclined 0.11% to $44.64, during its last trading session.
The U.S. Department of the Treasury awarded U.S. Bank’s community development entity, USBCDE LLC, the authority to raise $55 million in financing for low-income communities.
The award is part of a $3.5 billion New Markets Tax Credit (NMTC) allocation authority package declared this week by the Treasury’s Community Development Financial Institutions Fund. USBCDE is one of only 76 community development entities among 263 applicants that received allocation authority.
CDEs use allocation authority to attract private sector investments in disadvantaged communities that lack access to the long-term investment needed to support and grow businesses and create jobs. The program is an efficient and effective mechanism for infusing up-front capital in areas that need it most.
In addition to being an efficient tool for driving capital to underserved markets, the program also spurs economic development. Since its inception, the NMTC program has created or retained nearly 600,000 jobs and supported the construction of more than 160 million square feet of manufacturing, office and retail space in low-income communities across the country.
U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which comprise checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, in addition to credit card services, leasing, financing and import/export trade, asset-backed lending, agricultural finance, and other products.
Finally, Nivalis Therapeutics, Inc. (NASDAQ:NVLS), ended its last trade with 6.57% gain, and closed at $14.92.
Nivalis Therapeutics, declared the pricing of its initial public offering of 5.5 million shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions.
In addition, Nivalis has granted the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares of the common stock in this offering are being sold by Nivalis.
Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). CF is a life-shortening genetic disease. Its lead product candidate is N91115, a small molecule that is in Phase Ib clinical trial, which addresses a defect in cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR gene.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
